JPS5936678A
(ja)
*
|
1982-07-26 |
1984-02-28 |
Bristol Mayers Kenkyusho Kk |
抗腫瘍抗生物質
|
US4464467A
(en)
*
|
1982-07-26 |
1984-08-07 |
Bristol-Myers Company |
Antitumor antibiotics produced by new streptomyces
|
JPH0521909B2
(ja)
*
|
1982-07-26 |
1993-03-25 |
Burisutoru Maiyaazu Kenkyusho Kk |
|
US7067511B2
(en)
|
1998-08-27 |
2006-06-27 |
Spirogen Limited |
Pyrrolobenzodiazepines
|
US7704924B2
(en)
|
1998-08-27 |
2010-04-27 |
Spirogen Limited |
Library of compounds comprising pyrrolobenzodiazepine moieties
|
EP1193270A3
(en)
*
|
1998-08-27 |
2002-04-17 |
Spirogen Limited |
Pyrrolobenzodiazepines
|
US6608192B1
(en)
|
1998-08-27 |
2003-08-19 |
Spirogen Limited |
Collections of compounds
|
US6747144B1
(en)
|
1998-08-27 |
2004-06-08 |
Spirogen Limited |
Collections of compounds
|
WO2000012508A3
(en)
*
|
1998-08-27 |
2000-09-21 |
Univ Portsmouth |
Pyrrolbenzodiazepines
|
US7049311B1
(en)
|
1998-08-27 |
2006-05-23 |
Spirogen Limited |
Pyrrolbenzodiazepines
|
WO2000012509A3
(en)
*
|
1998-08-27 |
2000-07-06 |
Univ Portsmouth |
Collections of compounds
|
US7265105B2
(en)
|
1998-08-27 |
2007-09-04 |
Spirogen Limited |
Pyrrolobenzodiazepines
|
JP4824165B2
(ja)
*
|
1998-08-27 |
2011-11-30 |
スパイロジエン・リミテツド |
ピロロベンゾジアゼピン類
|
US6909006B1
(en)
|
1999-08-27 |
2005-06-21 |
Spirogen Limited |
Cyclopropylindole derivatives
|
US7407951B2
(en)
|
2002-11-14 |
2008-08-05 |
Spirogen Limited |
Pyrrolobenzodiazepines
|
US7429658B2
(en)
|
2003-09-11 |
2008-09-30 |
Spirogen Limited |
Synthesis of protected pyrrolobenzodiazepines
|
US7557099B2
(en)
|
2004-03-01 |
2009-07-07 |
Spirogen Limited |
Pyrrolobenzodiazepines as key intermediates in the synthesis of dimeric cytotoxic pyrrolobenzodiazepines
|
US7741319B2
(en)
|
2004-03-01 |
2010-06-22 |
Spirogen Limited |
11-hydroxy-5h-pyrrolo[2,1-c][1,4] benzodiazepin-5-one derivatives as key intermediates for the preparation of c2 substituted pyrrolobenzodiazepines
|
US7528126B2
(en)
|
2004-03-09 |
2009-05-05 |
Spirogen Limited |
Pyrrolobenzodiazepines
|
US8940733B2
(en)
|
2008-10-17 |
2015-01-27 |
Spirogen Sarl |
Unsymmetrical pyrrolobenzodiazepine-dimers for treatment of proliferative diseases
|
US9624227B2
(en)
|
2008-10-17 |
2017-04-18 |
Medimmune Limited |
Unsymmetrical pyrrolobenzodiazepine-dimers for treatment of proliferative diseases
|
US8592576B2
(en)
|
2008-10-17 |
2013-11-26 |
Spirogen Sarl |
Unsymmetrical pyrrolobenzodiazepine-dimers for treatment of proliferative diseases
|
US9550787B2
(en)
|
2009-02-05 |
2017-01-24 |
Immunogen, Inc. |
Benzodiazepine derivatives
|
EP2393362A4
(en)
*
|
2009-02-05 |
2013-07-24 |
Immunogen Inc |
NEW BENZODIAZEPINE DERIVATIVES
|
US8809320B2
(en)
|
2009-02-05 |
2014-08-19 |
Immunogen, Inc. |
Benzodiazepine derivatives
|
CN108727407A
(zh)
*
|
2009-02-05 |
2018-11-02 |
伊缪诺金公司 |
新型苯并二氮杂*衍生物
|
EP2393362A1
(en)
*
|
2009-02-05 |
2011-12-14 |
Immunogen, Inc. |
Novel benzodiazepine derivatives
|
US10208127B2
(en)
|
2009-02-05 |
2019-02-19 |
Immunogen, Inc. |
Benzodiazepine derivatives
|
US10947315B2
(en)
|
2009-02-05 |
2021-03-16 |
Immunogen, Inc. |
Benzodiazepine derivatives
|
US8802667B2
(en)
|
2009-02-05 |
2014-08-12 |
Immunogen, Inc. |
Benzodiazepine derivatives
|
JP2015187144A
(ja)
*
|
2009-02-05 |
2015-10-29 |
イミュノジェン・インコーポレーテッド |
新規ベンゾジアゼピン誘導体
|
AU2010210646B2
(en)
*
|
2009-02-05 |
2015-10-29 |
Immunogen, Inc. |
Novel benzodiazepine derivatives
|
JP2018021056A
(ja)
*
|
2009-02-05 |
2018-02-08 |
イミュノジェン・インコーポレーテッド |
新規ベンゾジアゼピン誘導体
|
US9265841B2
(en)
|
2009-02-05 |
2016-02-23 |
Immunogen, Inc. |
Benzodiazepine derivatives
|
US11505617B2
(en)
|
2009-02-05 |
2022-11-22 |
Immunogen, Inc. |
Benzodiazepine derivatives
|
AU2019202435B2
(en)
*
|
2009-02-05 |
2021-04-01 |
Immunogen, Inc. |
Novel benzodiazepine derivatives
|
EP3100745A1
(en)
*
|
2009-02-05 |
2016-12-07 |
Immunogen, Inc. |
Novel benzodiazepine derivatives
|
AU2015224492B2
(en)
*
|
2009-02-05 |
2017-04-20 |
Immunogen, Inc. |
Novel benzodiazepine derivatives
|
EP3360879A1
(en)
*
|
2009-02-05 |
2018-08-15 |
ImmunoGen, Inc. |
Benzodiazepine derivatives as cytotoxic agents
|
US9242013B2
(en)
|
2010-04-15 |
2016-01-26 |
Seattle Genetics Inc. |
Targeted pyrrolobenzodiazapine conjugates
|
US9732084B2
(en)
|
2010-04-15 |
2017-08-15 |
Medimmune Limited |
Pyrrolobenzodiazepines used to treat proliferative diseases
|
US10561739B2
(en)
|
2010-04-15 |
2020-02-18 |
Seattle Genetics Inc. |
Targeted pyrrolobenzodiazapine conjugates
|
US8829184B2
(en)
|
2010-04-15 |
2014-09-09 |
Spirogen Sarl |
Intermediates useful for the synthesis of pyrrolobenzodiazepines
|
US9840564B2
(en)
|
2011-02-15 |
2017-12-12 |
Immunogen, Inc. |
Cytotoxic benzodiazepine derivatives
|
US9353127B2
(en)
|
2011-02-15 |
2016-05-31 |
Immunogen, Inc. |
Methods of preparation of conjugates
|
US9534000B2
(en)
|
2011-02-15 |
2017-01-03 |
Immunogen, Inc. |
Cytotoxic benzodiazepine derivatives and methods of preparation
|
US9868791B2
(en)
|
2011-02-15 |
2018-01-16 |
Immunogen, Inc. |
Methods of preparation of conjugates
|
US10570212B2
(en)
|
2011-02-15 |
2020-02-25 |
Immunogen, Inc. |
Cytotoxic benzodiazepine derivatives
|
US10364294B2
(en)
|
2011-02-15 |
2019-07-30 |
Immunogen, Inc. |
Methods of preparation of conjugates
|
US9169272B2
(en)
|
2011-02-15 |
2015-10-27 |
Immunogen, Inc. |
Cytotoxic benzodiazepine derivatives
|
US8765740B2
(en)
|
2011-02-15 |
2014-07-01 |
Immunogen, Inc. |
Cytotoxic benzodiazepine derivatives
|
US10179818B2
(en)
|
2011-02-15 |
2019-01-15 |
Immunogen, Inc. |
Cytotoxic benzodiazepine derivatives
|
US8889669B2
(en)
|
2011-02-15 |
2014-11-18 |
Immunogen, Inc. |
Cytotoxic benzodiazepine derivatives
|
USRE49918E1
(en)
|
2011-02-15 |
2024-04-16 |
Immunogen, Inc. |
Cytotoxic benzodiazepine derivatives
|
US9434748B2
(en)
|
2011-02-15 |
2016-09-06 |
Immunogen, Inc. |
Cytotoxic benzodiazepine derivatives
|
US10329352B2
(en)
|
2011-10-14 |
2019-06-25 |
Seattle Genetics, Inc. |
Pyrrolobenzodiazepines and targeted conjugates
|
US10328084B2
(en)
|
2011-10-14 |
2019-06-25 |
Seattle Genetics, Inc. |
Pyrrolobenzodiazepines and targeted conjugates
|
US9102704B2
(en)
|
2011-10-14 |
2015-08-11 |
Spirogen Sarl |
Synthesis method and intermediates useful in the preparation of pyrrolobenzodiazepines
|
US9707301B2
(en)
|
2011-10-14 |
2017-07-18 |
Seattle Genetics, Inc. |
Pyrrolobenzodiazepines and targeted conjugates
|
US9713647B2
(en)
|
2011-10-14 |
2017-07-25 |
Seattle Genetics, Inc. |
Pyrrolobenzodiazepines and targeted conjugates
|
US9745303B2
(en)
|
2012-10-12 |
2017-08-29 |
Medimmune Limited |
Synthesis and intermediates of pyrrolobenzodiazepine derivatives for conjugation
|
US11779650B2
(en)
|
2012-10-12 |
2023-10-10 |
Medimmune Limited |
Pyrrolobenzodiazepine-antibody conjugates
|
US9919056B2
(en)
|
2012-10-12 |
2018-03-20 |
Adc Therapeutics S.A. |
Pyrrolobenzodiazepine-anti-CD22 antibody conjugates
|
US10335497B2
(en)
|
2012-10-12 |
2019-07-02 |
Medimmune Limited |
Pyrrolobenzodiazepines and conjugates thereof
|
US9889207B2
(en)
|
2012-10-12 |
2018-02-13 |
Medimmune Limited |
Pyrrolobenzodiazepines and conjugates thereof
|
US11690918B2
(en)
|
2012-10-12 |
2023-07-04 |
Medimmune Limited |
Pyrrolobenzodiazepine-anti-CD22 antibody conjugates
|
US11701430B2
(en)
|
2012-10-12 |
2023-07-18 |
Medimmune Limited |
Pyrrolobenzodiazepines and conjugates thereof
|
US10994023B2
(en)
|
2012-10-12 |
2021-05-04 |
Medimmune Limited |
Pyrrolobenzodiazepines and conjugates thereof
|
US9931415B2
(en)
|
2012-10-12 |
2018-04-03 |
Medimmune Limited |
Pyrrolobenzodiazepine-antibody conjugates
|
US9931414B2
(en)
|
2012-10-12 |
2018-04-03 |
Medimmune Limited |
Pyrrolobenzodiazepine-antibody conjugates
|
US10780181B2
(en)
|
2012-10-12 |
2020-09-22 |
Medimmune Limited |
Pyrrolobenzodiazepine-antibody conjugates
|
US10646584B2
(en)
|
2012-10-12 |
2020-05-12 |
Medimmune Limited |
Pyrrolobenzodiazepines and conjugates thereof
|
US11771775B2
(en)
|
2012-10-12 |
2023-10-03 |
Medimmune Limited |
Pyrrolobenzodiazepine-antibody conjugates
|
US10695433B2
(en)
|
2012-10-12 |
2020-06-30 |
Medimmune Limited |
Pyrrolobenzodiazepine-antibody conjugates
|
US10722594B2
(en)
|
2012-10-12 |
2020-07-28 |
Adc Therapeutics S.A. |
Pyrrolobenzodiazepine-anti-CD22 antibody conjugates
|
US10736903B2
(en)
|
2012-10-12 |
2020-08-11 |
Medimmune Limited |
Pyrrolobenzodiazepine-anti-PSMA antibody conjugates
|
US10751346B2
(en)
|
2012-10-12 |
2020-08-25 |
Medimmune Limited |
Pyrrolobenzodiazepine—anti-PSMA antibody conjugates
|
US10799596B2
(en)
|
2012-10-12 |
2020-10-13 |
Adc Therapeutics S.A. |
Pyrrolobenzodiazepine-antibody conjugates
|
US9950078B2
(en)
|
2013-10-11 |
2018-04-24 |
Medimmune Limited |
Pyrrolobenzodiazepine-antibody conjugates
|
US10029018B2
(en)
|
2013-10-11 |
2018-07-24 |
Medimmune Limited |
Pyrrolobenzodiazepines and conjugates thereof
|
US10010624B2
(en)
|
2013-10-11 |
2018-07-03 |
Medimmune Limited |
Pyrrolobenzodiazepine-antibody conjugates
|
US9956299B2
(en)
|
2013-10-11 |
2018-05-01 |
Medimmune Limited |
Pyrrolobenzodiazepine—antibody conjugates
|
US9956298B2
(en)
|
2013-10-11 |
2018-05-01 |
Medimmune Limited |
Pyrrolobenzodiazepines and conjugates thereof
|
US10420777B2
(en)
|
2014-09-12 |
2019-09-24 |
Medimmune Limited |
Pyrrolobenzodiazepines and conjugates thereof
|
US10780096B2
(en)
|
2014-11-25 |
2020-09-22 |
Adc Therapeutics Sa |
Pyrrolobenzodiazepine-antibody conjugates
|
US11059893B2
(en)
|
2015-04-15 |
2021-07-13 |
Bergenbio Asa |
Humanized anti-AXL antibodies
|
US11702473B2
(en)
|
2015-04-15 |
2023-07-18 |
Medimmune Limited |
Site-specific antibody-drug conjugates
|
US10392393B2
(en)
|
2016-01-26 |
2019-08-27 |
Medimmune Limited |
Pyrrolobenzodiazepines
|
US10695439B2
(en)
|
2016-02-10 |
2020-06-30 |
Medimmune Limited |
Pyrrolobenzodiazepine conjugates
|
US11517626B2
(en)
|
2016-02-10 |
2022-12-06 |
Medimmune Limited |
Pyrrolobenzodiazepine antibody conjugates
|
US10543279B2
(en)
|
2016-04-29 |
2020-01-28 |
Medimmune Limited |
Pyrrolobenzodiazepine conjugates and their use for the treatment of cancer
|
US10799595B2
(en)
|
2016-10-14 |
2020-10-13 |
Medimmune Limited |
Pyrrolobenzodiazepine conjugates
|
US11160872B2
(en)
|
2017-02-08 |
2021-11-02 |
Adc Therapeutics Sa |
Pyrrolobenzodiazepine-antibody conjugates
|
US11612665B2
(en)
|
2017-02-08 |
2023-03-28 |
Medimmune Limited |
Pyrrolobenzodiazepine-antibody conjugates
|
US11813335B2
(en)
|
2017-02-08 |
2023-11-14 |
Medimmune Limited |
Pyrrolobenzodiazepine-antibody conjugates
|
US11370801B2
(en)
|
2017-04-18 |
2022-06-28 |
Medimmune Limited |
Pyrrolobenzodiazepine conjugates
|
US10544223B2
(en)
|
2017-04-20 |
2020-01-28 |
Adc Therapeutics Sa |
Combination therapy with an anti-axl antibody-drug conjugate
|
US11318211B2
(en)
|
2017-06-14 |
2022-05-03 |
Adc Therapeutics Sa |
Dosage regimes for the administration of an anti-CD19 ADC
|
US11938192B2
(en)
|
2017-06-14 |
2024-03-26 |
Medimmune Limited |
Dosage regimes for the administration of an anti-CD19 ADC
|
US11649250B2
(en)
|
2017-08-18 |
2023-05-16 |
Medimmune Limited |
Pyrrolobenzodiazepine conjugates
|
US11628223B2
(en)
|
2017-09-29 |
2023-04-18 |
Daiichi Sankyo Company, Limited |
Antibody-drug conjugates comprising substituted benzo[e]pyrrolo[1,2-α][1,4]diazepines
|
US11583590B2
(en)
|
2017-09-29 |
2023-02-21 |
Daiichi Sankyo Company, Limited |
Antibody-pyrrolobenzodiazepine derivative conjugate and method of use thereof for treating a tumor
|
US11352324B2
(en)
|
2018-03-01 |
2022-06-07 |
Medimmune Limited |
Methods
|
US11524969B2
(en)
|
2018-04-12 |
2022-12-13 |
Medimmune Limited |
Pyrrolobenzodiazepines and conjugates thereof as antitumour agents
|